Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob P Hoogendam

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Familial Cancer|August 13, 2015
The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomyJessica E van der Aa, Jacob P Hoogendam, Els S F Butter, et al.
The Cochrane Database of Systematic Reviews|October 10, 2018
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancerJoline F Roze, Jacob P Hoogendam, Fleur T van de Wetering, et al.
Gynecologic Oncology|October 26, 2013
Detection of cervical cancer recurrence during follow-up: a multivariable comparison of 9 frequently investigated serum biomarkersJacob P Hoogendam, Afra Zaal, Emma G G M Rutten, et al.
Plos One|July 3, 2015
No Value for Routine Chest Radiography in the Work-Up of Early Stage Cervical Cancer PatientsJacob P Hoogendam, Ronald P Zweemer, Helena M Verkooijen, et al.
BMJ Open|September 13, 2022
Fluorescent Indocyanine Green versus Technetium-99m and Blue Dye for Bilateral SENTinel Lymph Node Detection in Stage I-IIA Cervical Cancer (FluoreSENT): protocol for a non-inferiority studyIlse G T Baeten, Jacob P Hoogendam, Arthur J A T Braat, et al.
Cancer Reports (Hoboken, N.J.)|May 11, 2021
Indocyanine green versus technetium-99m with blue dye for sentinel lymph node detection in early-stage cervical cancer: A systematic review and meta-analysisIlse G T Baeten, Jacob P Hoogendam, Bernadette Jeremiasse, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 3, 2010
The influence of the b-value combination on apparent diffusion coefficient based differentiation between malignant and benign tissue in cervical cancerJacob P Hoogendam, Wenche M Klerkx, Gerard A P de Kort, et al.
Hereditary Cancer in Clinical Practice|September 8, 2022
Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testingKyra Bokkers, Eveline M A Bleiker, Jacob P Hoogendam, et al.
European Radiology|June 2, 2016
High-resolution T<sub>2</sub>-weighted cervical cancer imaging: a feasibility study on ultra-high-field 7.0-T MRI with an endorectal monopole antennaJacob P Hoogendam, Irene M L Kalleveen, Catalina S Arteaga de Castro, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Familial Cancer|August 13, 2015
The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomyJessica E van der Aa, Jacob P Hoogendam, Els S F Butter, et al.
The Cochrane Database of Systematic Reviews|October 10, 2018
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancerJoline F Roze, Jacob P Hoogendam, Fleur T van de Wetering, et al.
Gynecologic Oncology|October 26, 2013
Detection of cervical cancer recurrence during follow-up: a multivariable comparison of 9 frequently investigated serum biomarkersJacob P Hoogendam, Afra Zaal, Emma G G M Rutten, et al.
Plos One|July 3, 2015
No Value for Routine Chest Radiography in the Work-Up of Early Stage Cervical Cancer PatientsJacob P Hoogendam, Ronald P Zweemer, Helena M Verkooijen, et al.
BMJ Open|September 13, 2022
Fluorescent Indocyanine Green versus Technetium-99m and Blue Dye for Bilateral SENTinel Lymph Node Detection in Stage I-IIA Cervical Cancer (FluoreSENT): protocol for a non-inferiority studyIlse G T Baeten, Jacob P Hoogendam, Arthur J A T Braat, et al.
Cancer Reports (Hoboken, N.J.)|May 11, 2021
Indocyanine green versus technetium-99m with blue dye for sentinel lymph node detection in early-stage cervical cancer: A systematic review and meta-analysisIlse G T Baeten, Jacob P Hoogendam, Bernadette Jeremiasse, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 3, 2010
The influence of the b-value combination on apparent diffusion coefficient based differentiation between malignant and benign tissue in cervical cancerJacob P Hoogendam, Wenche M Klerkx, Gerard A P de Kort, et al.
Hereditary Cancer in Clinical Practice|September 8, 2022
Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testingKyra Bokkers, Eveline M A Bleiker, Jacob P Hoogendam, et al.
European Radiology|June 2, 2016
High-resolution T<sub>2</sub>-weighted cervical cancer imaging: a feasibility study on ultra-high-field 7.0-T MRI with an endorectal monopole antennaJacob P Hoogendam, Irene M L Kalleveen, Catalina S Arteaga de Castro, et al.
Pageof 2